Geoffrey Seidel, MD
Physical Medicine & Rehabilitation · Clinton Township, MINPI 1134127459
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations.
Across 143 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$516
- AbbVie$464
- Novartis$364
- Tanabe Pharma America, Inc.$176
- Acorda Therapeutics, Inc$166
- Lundbeck LLC$157
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$221%
- Food & beverage$2,83899%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 35 | $516 |
| AbbVie(2 entities) | 22 | $464 |
| Novartis | 21 | $364 |
| Tanabe Pharma America, Inc. | 5 | $176 |
| Acorda Therapeutics, Inc | 7 | $166 |
| Lundbeck LLC | 6 | $157 |
| Argenx US, Inc. | 6 | $150 |
| Neurelis, Inc. | 6 | $142 |
| Amgen | 6 | $103 |
| SK Life Science, Inc. | 3 | $94 |
| Teva Pharmaceuticals USA, Inc. | 6 | $90 |
| Neurocrine Biosciences, Inc. | 2 | $62 |
| Eisai Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $41 |
| Pfizer | 1 | $29 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Bausch Health US, LLC | 1 | $25 |
| AstraZeneca | 1 | $25 |
| Corium, LLC | 1 | $25 |
| Sanofi | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Promius Pharma LLC | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,860 in reported general payments places this provider in the 85th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 212 | $2,846 |
| Lidocaine | 18 | $1,471 |
| Baclofen | 46 | $1,195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $1,126 |
| Amitriptyline Hcl | 50 | $745 |
| Duloxetine Hcl | 31 | $635 |
| Prednisone | 128 | $435 |
| Tramadol Hcl | 47 | $332 |
| Ropinirole Hcl | 31 | $279 |
| Pregabalin | 33 | $264 |
| Ibuprofen | 14 | $168 |
| Diclofenac Sodium | 13 | $141 |
| Clonazepam | 14 | $132 |
| Meloxicam | 46 | $116 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 18 | $63 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Clinton Township
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
- Emily GladstoneGrand Rapids$10K
- In YoonDearborn$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.